Tofisopam (Emandaxin, Grandaxin, Sériel) is an anxiolytic that is marketed in several European countries. Chemically, it is a 2,3-benzodiazepine. Unlike...
9 KB (733 words) - 06:09, 9 February 2024
Opipramol Oxaflozane‡ Phenaglycodol Phenibut Picamilon Selank Tiagabine Tofisopam Validolum #WHO-EM ‡Withdrawn from market Clinical trials: †Phase III §Never...
87 KB (8,581 words) - 16:17, 12 May 2024
Opipramol Oxaflozane‡ Phenaglycodol Phenibut Picamilon Selank Tiagabine Tofisopam Validolum #WHO-EM ‡Withdrawn from market Clinical trials: †Phase III §Never...
68 KB (6,501 words) - 18:32, 8 May 2024
PF-04447943 Paraxanthine PDE10 Balipodect Mardepodect Papaverine TC-E 5005 Tofisopam PDE11 BC11-38 Non-selective Aminophylline Caffeine Choline theophyllinate...
70 KB (6,742 words) - 14:09, 3 May 2024
Opipramol Oxaflozane‡ Phenaglycodol Phenibut Picamilon Selank Tiagabine Tofisopam Validolum #WHO-EM ‡Withdrawn from market Clinical trials: †Phase III §Never...
102 KB (8,583 words) - 04:03, 7 May 2024
Opipramol Oxaflozane‡ Phenaglycodol Phenibut Picamilon Selank Tiagabine Tofisopam Validolum #WHO-EM ‡Withdrawn from market Clinical trials: †Phase III §Never...
51 KB (4,657 words) - 16:47, 25 March 2024
Opipramol Oxaflozane‡ Phenaglycodol Phenibut Picamilon Selank Tiagabine Tofisopam Validolum #WHO-EM ‡Withdrawn from market Clinical trials: †Phase III §Never...
34 KB (2,651 words) - 16:56, 2 May 2024
Opipramol Oxaflozane‡ Phenaglycodol Phenibut Picamilon Selank Tiagabine Tofisopam Validolum #WHO-EM ‡Withdrawn from market Clinical trials: †Phase III §Never...
86 KB (8,228 words) - 05:08, 3 May 2024
Opipramol Oxaflozane‡ Phenaglycodol Phenibut Picamilon Selank Tiagabine Tofisopam Validolum #WHO-EM ‡Withdrawn from market Clinical trials: †Phase III §Never...
158 KB (16,597 words) - 06:48, 15 May 2024
Opipramol Oxaflozane‡ Phenaglycodol Phenibut Picamilon Selank Tiagabine Tofisopam Validolum #WHO-EM ‡Withdrawn from market Clinical trials: †Phase III §Never...
54 KB (4,794 words) - 13:24, 21 April 2024